undamentalytics Newsletter
Sign in

Burning Rock Biotech Ltd revenue

Burning Rock Biotech Ltd's revenue was $75.1m in fiscal 2025, up 4.7% on the year before. Since fiscal 2018 ($31.7m) it has grown at a compound 13.1% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Revenue3255627984767275
Growth on the year before—+74.6%+12.7%+26.4%+6.5%−9.4%−5.6%+4.7%
Gross profit2040465657515056

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Burning Rock Biotech Ltd $75.1m 4.7% —
Codexis, Inc. $77.7m 35.9% -7.8%
Exagen Inc. $71.1m 20.8% 10.3%
Personalis, Inc. $69.7m -13.3% 1.2%
Harvard Bioscience Inc $87.8m -1.1% -8.4%
908 Devices Inc. $60.8m 13.4% 7.5%

Compare with peers

Head to head: BNR vs CDXSBNR vs XGNBNR vs PSNLBNR vs HBIO

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Burning Rock Biotech Ltd's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Burning Rock Biotech Ltd.